Literatur

Probiotic Escherichia coli Nissle 1917 versus placebo for treating diarrhea of greater than 4 days duration in infants and toddlers.

In: Pediatr. Infect. Dis. J. 27 (6), S. 494–499.

Weitere Veröffentlichungen:

Probiotic Escherichia coli Nissle 1917 (EcN) for successful remission maintenance of ulcerative colitis in children and adolescents. An open-label pilot study.

Weitere Informationen

The probiotic Escherichia coli strain Nissle 1917 (EcN) stops acute diarrhoea in infants and toddlers

Weitere Informationen

Effect of preventive administration of a nonpathogenic Escherichia coli strain on the colonization of the intestine with microbial pathogens in newborn infants.

Weitere Informationen

Henker, J.; Laass, M. W.; Blokhin, B. M.; Maydannik, V. G.; Bolbot, Y. K.; Elze, M. et al. (2008): Probiotic Escherichia coli Nissle 1917 versus placebo for treating diarrhea of greater than 4 days duration in infants and toddlers.